1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA FUBP1 CTRPv2 pan-cancer AAC 0.18 9e-08
mRNA ROMO1 CTRPv2 pan-cancer AAC -0.17 9e-08
mRNA PDS5B CTRPv2 pan-cancer AAC 0.18 9e-08
mRNA DUSP15 CTRPv2 pan-cancer AAC 0.17 9e-08
mRNA NEURL1B CTRPv2 pan-cancer AAC 0.17 1e-07
mRNA FBXO15 CTRPv2 pan-cancer AAC 0.17 1e-07
mRNA KIF15 CTRPv2 pan-cancer AAC 0.19 1e-07
mRNA AGBL4 CTRPv2 pan-cancer AAC 0.17 1e-07
mRNA RBM14 CTRPv2 pan-cancer AAC 0.18 1e-07
mRNA RP11-458D21.5 CTRPv2 pan-cancer AAC -0.17 1e-07
Download CSV